Jane Street Group LLC Has $531,000 Stake in Simulations Plus, Inc. (NASDAQ:SLP)

Jane Street Group LLC decreased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 17.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,569 shares of the technology company’s stock after selling 3,435 shares during the quarter. Jane Street Group LLC owned 0.08% of Simulations Plus worth $531,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in SLP. Bank of New York Mellon Corp raised its position in shares of Simulations Plus by 5.2% during the second quarter. Bank of New York Mellon Corp now owns 222,317 shares of the technology company’s stock worth $10,809,000 after purchasing an additional 11,048 shares during the period. Arizona State Retirement System acquired a new stake in shares of Simulations Plus during the second quarter worth about $218,000. Los Angeles Capital Management LLC acquired a new stake in shares of Simulations Plus during the second quarter worth about $206,000. Wedbush Securities Inc. raised its position in shares of Simulations Plus by 10.5% during the second quarter. Wedbush Securities Inc. now owns 18,025 shares of the technology company’s stock worth $876,000 after purchasing an additional 1,709 shares during the period. Finally, Envestnet Asset Management Inc. raised its position in shares of Simulations Plus by 1.5% during the second quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock worth $2,665,000 after purchasing an additional 784 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. BTIG Research dropped their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Finally, Stephens assumed coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 price objective for the company. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $51.40.

Simulations Plus Stock Up 2.9 %

SLP stock opened at $28.73 on Monday. The business has a 50 day moving average price of $29.82 and a two-hundred day moving average price of $34.38. The company has a market cap of $577.04 million, a price-to-earnings ratio of 58.63 and a beta of 0.80. Simulations Plus, Inc. has a twelve month low of $27.07 and a twelve month high of $51.22.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same period in the previous year, the company posted $0.18 EPS. The firm’s revenue for the quarter was up 19.9% compared to the same quarter last year. On average, equities research analysts anticipate that Simulations Plus, Inc. will post 1.1 EPS for the current fiscal year.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the sale, the director now directly owns 3,462,584 shares of the company’s stock, valued at approximately $95,775,073.44. This trade represents a 0.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 19.40% of the stock is currently owned by corporate insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.